Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting

Joshua Aviram

doi:10.1007/s00213-025-06883-y

Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting

Joshua Aviram

Research output: Contribution to journal › Comment/Debate

Original language	English
Journal	Psychopharmacology
Early online date	15 Aug 2025
DOIs	https://doi.org/10.1007/s00213-025-06883-y
State	E-pub ahead of print - 15 Aug 2025
Externally published	Yes

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1007/s00213-025-06883-y

Cite this

@article{c2b0e7655a4448e4869e6e9e57757201,

title = "Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting",

author = "Joshua Aviram",

year = "2025",

month = aug,

day = "15",

doi = "10.1007/s00213-025-06883-y",

language = "English",

journal = "Psychopharmacology",

issn = "0033-3158",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Response to Barner et al. (2025) on comment on Zabik et al. (2024)

T2 - special considerations for cannabis research in RCTs and feasibility in a clinical setting

AU - Aviram, Joshua

PY - 2025/8/15

Y1 - 2025/8/15

UR - https://www.scopus.com/pages/publications/105013473585

U2 - 10.1007/s00213-025-06883-y

DO - 10.1007/s00213-025-06883-y

M3 - Comment/Debate

C2 - 40815407

AN - SCOPUS:105013473585

SN - 0033-3158

JO - Psychopharmacology

JF - Psychopharmacology

ER -

Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this